Patients presenting with no symptoms, and not affected by the syndrome may not require treatment. Corticosteroids have been reported to be of benefit in select patients. Bronchodilators may assist with breathing issues. Resolution may occur with the use of highly active anti-retroviral therapy used in patients with HIV, which suggests that the virus alone may cause immune cells to proliferate, or immunosuppression caused by HIV may lead to other viruses that induce the proliferation of immune cells, leading to LIP. There has been a decreased association of HIV and LIP since the introduction of antiretroviral therapy. However, responses to different treatments are widely varied, and no single first line treatment represents the default treatment for<unk> .
Lymphocytic interstitial pneumonia
Desquamative interstitial pneumonia
Usual interstitial pneumonia
Non-specific interstitial pneumonia
Granulomatous–lymphocytic interstitial lung disease
Diffuse panbronchiolitis
Diffuse alveolar damage
Pulmonary alveolar microlithiasis